Related references
Note: Only part of the references are listed.Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond
Rachel A. Freedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019
Reed Magleby et al.
CLINICAL INFECTIOUS DISEASES (2021)
Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis
Yan Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
Laura M. Spring et al.
CLINICAL CANCER RESEARCH (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
H. Miyashita et al.
ANNALS OF ONCOLOGY (2020)
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium
Jill R. Dietz et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Repositioning PARP inhibitors for SARS-CoV-2 infection(COVID-19); a new multi-pronged therapy for acute respiratory distress syndrome?
Nicola Curtin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
COVID-19: Safe Guidelines for Breast Imaging During the Pandemic
Jean M. Seely et al.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES (2020)
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019
Xiaohua Chen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak
Yeshan Chen et al.
GYNECOLOGIC ONCOLOGY (2020)
Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?
Joseph Kattan et al.
IMMUNOTHERAPY (2020)
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Melissa Bersanelli
IMMUNOTHERAPY (2020)
Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).
XI Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
In Vitro and Animal Models for SARS-CoV-2 research
Kazuo Takayama
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Mengyuan Dai et al.
CANCER DISCOVERY (2020)
Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry
Jian Shang et al.
PLoS Pathogens (2020)
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
Wenhua Liang et al.
JAMA INTERNAL MEDICINE (2020)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Cancer and COVID-19-potentially deleterious effects of delaying radiotherapy
Himanshu Nagar et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak
Giulia Viale et al.
ONCOLOGIST (2020)
Preparing for the renaissance: treating breast cancer during the COVID-19 pandemic and planning for a safe re-emergence to routine surgical care within a universal health care system
D. Berger-Richardson et al.
CURRENT ONCOLOGY (2020)
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic
Giuseppe Curigliano et al.
BREAST (2020)
Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China
Jing Yao et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic
Elizabeth Lerner Papautsky et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic
Hagar Elghazawy et al.
Future Oncology (2020)
Breast imaging, breast surgery, and cancer genetics in the age of COVID-19
Kanhua Yin et al.
CANCER (2020)
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors
Patrizia Vici et al.
IMMUNOTHERAPY (2020)
Breast Cancer Management Guidelines During COVID-19 Pandemic
Manoj S. Gowda et al.
INDIAN JOURNAL OF SURGERY (2020)
Surgical Management Strategy for Breast Cancer Patients During the COVID-19 Outbreak
Yong Liu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Oncolytic Viruses and the Immune System: The Dynamic Duo
Ana Lemos de Matos et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
Evandro de Azambuja et al.
ESMO OPEN (2020)
The Virtual Scientific Sessions from the American Society of Breast Surgeons During the COVID-19 Pandemic
Henry M. Kuerer et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics
Johny E. Fares et al.
CANCER TREATMENT REVIEWS (2020)
GEICAMGuidelines for the Management of Patients with Breast Cancer During theCOVID-19 Pandemic in Spain
Miguel Martin et al.
ONCOLOGIST (2020)
The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience
Jack Junjie Chan et al.
ENDOCRINE-RELATED CANCER (2020)
COVID-19 and gynecological cancers: A Moroccan point-of-view
Nabil Ismaili
RADIOTHERAPY AND ONCOLOGY (2020)
Is Elective Cancer Surgery Safe During the COVID-19 Pandemic?
Chenchen Ji et al.
WORLD JOURNAL OF SURGERY (2020)
Pulmonary and pleural metastasis mimicking COVID-19 infection in stage IV ovarian cancer: a case report
Fabiana Carbone et al.
TUMORI JOURNAL (2020)
Suggestion of Tunisia's medical oncologist in the management of breast cancer during COVID-19 pandemic
Yosra Yahyaoui et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2020)
Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak
Atakan Sezer et al.
TURKISH JOURNAL OF SURGERY (2020)
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities
Francesca Poggio et al.
JCO ONCOLOGY PRACTICE (2020)
The Challenge of COVID-19: The Biological Characteristics and Outcomes in a Series of 130 Breast Cancer Patients Operated on During the Pandemic
Abdalla Saad Abdalla Al-zawil et al.
CHIRURGIA (2020)
Breast Reconstruction in a Coronavirus Disease 2019 Hub
Andrea Lisa et al.
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN (2020)
Breast Cancer Surgery During the COVID-19 Pandemic Peak in the UK: Operative Outcomes
Emma G. MacInnes et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
A practical approach to the management of breast cancer in the COVID-19 era and beyond
Alison Luther et al.
ECANCERMEDICALSCIENCE (2020)
COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis
Aakash Desai et al.
JCO GLOBAL ONCOLOGY (2020)
Regional Lymph Node Irradiation in Breast Cancer May Worsen Lung Damage in Coronavirus Disease 2019 Positive Patients
Noemie Grellier et al.
ADVANCES IN RADIATION ONCOLOGY (2020)
Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraintsd-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States
Lior Z. Braunstein et al.
ADVANCES IN RADIATION ONCOLOGY (2020)
Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment
H. Picchi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies
Ming Yuan He et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Integrative clinical genomics of metastatic cancer
Dan R. Robinson et al.
NATURE (2017)
Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients
Rachel A. Sanford et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma
Maria Del Castillo et al.
CLINICAL INFECTIOUS DISEASES (2016)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Pattern of metastatic spread in triple-negative breast cancer
Rebecca Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Share Paper
